Literature DB >> 879742

Cephradine penetration into cerebrospinal fluid and effects of its administration into the cerebral ventricles of cats.

S I Harik, K F Akl, M Uwaydah.   

Abstract

In cats that had high, sustained serum concentrations of cephradine, penetration of the drug into the cerebrospinal fluid (CSF) was poor. Serum cephradine levels were, on the average, 100-fold higher than the CSF levels. On the other hand, the direct injection of cephradine into the lateral cerebral ventricles of cats yielded high CSF cephradine concentrations without evidence of central nervous system toxicity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 879742      PMCID: PMC352095          DOI: 10.1128/AAC.11.5.909

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Development of meningitis during cephalothin therapy.

Authors:  R J Mangi; R S Kundargi; R Quintiliani; V T Andriole
Journal:  Ann Intern Med       Date:  1973-03       Impact factor: 25.391

2.  Penetration of cephalothin into the spinal fluid.

Authors:  N J Vianna; D Kaye
Journal:  Am J Med Sci       Date:  1967-08       Impact factor: 2.378

3.  Treatment of pneumococcal meningitis with cephaloridine.

Authors:  W C Love; P McKenzie; J H Lawson; I W Pinkerton; W M Jamieson; J Stevenson; W Roberts; A B Christie
Journal:  Postgrad Med J       Date:  1970-10       Impact factor: 2.401

4.  Penetration of cephalothin and lincomycin into the cerebrospinal fluid.

Authors:  P I Lerner
Journal:  Am J Med Sci       Date:  1969-02       Impact factor: 2.378

5.  Pharmacokinetics and penetration characteristics of cefazolin into human spinal fluid.

Authors:  H P Bassaris; R Quintiliani; E G Maderazo; R C Tilton; C H Nightingale
Journal:  Curr Ther Res Clin Exp       Date:  1976-01

6.  Cephalothin and cephaloridine therapy for bacterial meningitis.

Authors:  L S Fisher; A W Chow; T T Yoshikawa; L B Guze
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.